Received Jun 22, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
suffering symptoms of neurological damage; This is a spontaneous report received from a Consumer or other non HCP. An adult female patient (unknown if pregnant) received BNT162b2 (COMIRNATY), in Jan2021 as dose number unknown, single (Batch/Lot number: unknown) and in 2021 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NERVOUS SYSTEM DISORDER (non-serious), outcome "unknown", described as "suffering symptoms of neurological damage". It was unknown if therapeutic measures were taken as a result of nervous system disorder. Additional information: A patient was reported to be suffering from symptoms of neurological damage. The patient had reportedly been healthy prior to the onset of symptoms, which began after receiving two doses of a COVID-19 vaccine in 2021, administered 21 days apart. When asked for the patients medical history and additional details, no further information was provided. The patient did not receive any other vaccines on the same date as the reported vaccines. The information regarding receipt of any other vaccines within four weeks prior to the reported vaccines was unknown. It was also unknown whether the patient had been taking any other medications within two weeks before the onset of the event.It was also unknown whether the patient had any allergy with any drug. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.